Indogulf Cropsciences receivables rise as cash flow stays negative

Indogulf Cropsciences Limited recorded a Rs 133.14 crore rise in trade receivables in the six months ended September 30, 2026, from Rs 240.57 crore at March 31. The increase exceeded Rs 51.70 crore of operating profit before working-capital changes, leaving Indogulf Cropsciences with Rs 14.18 crore of cash used in operating activities.

What caused Indogulf Cropsciences' negative operating cash flow?

Indogulf Cropsciences used Rs 14.18 crore in operating activities in the half year ended September 30, 2026, compared with Rs 81.69 crore used in the corresponding 2025 half year. Operating profit before working-capital changes was Rs 51.70 crore, up from Rs 44.03 crore a year earlier, but the improvement did not offset cash absorbed by receivables.

The cash-flow statement records a Rs 133.14 crore increase in trade receivables, the largest listed operating working-capital movement for the six months. Inventories increased by Rs 6.09 crore, while trade payables increased by Rs 66.40 crore, partly offsetting the receivables outflow. Cash used in operations was Rs 12.44 crore before income-tax payments of Rs 1.73 crore.

The operating cash deficit narrowed by Rs 67.51 crore from the prior-year half year, when receivables had also absorbed Rs 132.08 crore. The year-on-year reduction in cash used reflects the lower overall working-capital drain, although the September 2026 half-year statement still reports a negative operating cash-flow outcome.

How did Indogulf Cropsciences' working-capital balances change?

Indogulf Cropsciences' trade receivables rose to Rs 373.71 crore at September 30, 2026, from Rs 240.57 crore at March 31, 2026. This Rs 133.14 crore balance-sheet movement matches the receivables outflow reported in the consolidated cash-flow statement for the half year.

Trade payables to parties other than micro and small enterprises increased by Rs 65.26 crore to Rs 180.71 crore. Payables to micro and small enterprises increased by Rs 1.14 crore to Rs 13.58 crore. Together, those changes broadly correspond with the Rs 66.40 crore increase in trade payables shown in the cash-flow statement.

Other current assets declined to Rs 56.56 crore at September 30 from Rs 67.78 crore at the March year-end, producing a Rs 11.96 crore operating cash inflow. Total current assets nevertheless increased to Rs 798.46 crore from Rs 674.72 crore, while current liabilities rose to Rs 433.41 crore from Rs 347.63 crore.

Indogulf Cropsciences reports one agro-chemical segment comprising Technical and Formulation activities. The September 30 filing does not provide a receivables ageing schedule, customer concentration data, collection target or stated explanation for the rise in trade receivables.

Did Indogulf Cropsciences' profit rise despite lower revenue?

Indogulf Cropsciences reported consolidated profit of Rs 28.10 crore for the half year ended September 30, 2026, up from Rs 24.55 crore in the corresponding 2025 period. Revenue from operations declined to Rs 424.32 crore from Rs 437.72 crore, a reduction of Rs 13.40 crore, while profit before tax rose to Rs 38.31 crore from Rs 31.77 crore.

Raw-material and component consumption declined to Rs 295.03 crore from Rs 325.94 crore, and purchases of traded goods fell to Rs 16.72 crore from Rs 23.76 crore. These reductions occurred alongside a Rs 3.53 crore increase in profit for the period, even as finance costs increased to Rs 8.61 crore from Rs 8.37 crore.

Depreciation and amortisation increased to Rs 5.60 crore in the September 2026 half year from Rs 5.05 crore a year earlier. The contrast between Rs 28.10 crore of reported profit and Rs 14.18 crore of operating cash used shows that working-capital movements, rather than the income statement result, determined cash conversion during the period.

For the September 2026 quarter, Indogulf Cropsciences reported profit of Rs 25.68 crore, compared with Rs 2.41 crore in the June 2026 quarter and Rs 20.69 crore in the September 2025 quarter. Quarterly revenue was Rs 255.78 crore, versus Rs 168.55 crore in the preceding quarter. The board approved the unaudited consolidated results on November 2, 2026.

How did Indogulf Cropsciences' cash and financing flows change?

Indogulf Cropsciences generated Rs 16.52 crore from financing activities in the six months to September 30, 2026, compared with Rs 112.74 crore in the previous-year period. The 2026 financing inflow included Rs 25.06 crore of proceeds from short-term borrowings and Rs 1.35 crore from long-term borrowings, offset by Rs 8.36 crore of interest paid and Rs 1.53 crore of lease-liability payments.

Investing activities used Rs 6.21 crore in the September 2026 half year, compared with Rs 28.73 crore used a year earlier. Additions to property, plant, equipment and intangible assets were Rs 9.13 crore, while investment additions were Rs 10.02 crore and proceeds from sale of investments were Rs 12.19 crore.

Cash and cash equivalents fell by Rs 3.87 crore during the six months to Rs 8.45 crore at September 30, 2026. The closing balance comprised Rs 6.97 crore of deposits with remaining maturities between three and 12 months, Rs 1.35 crore in current accounts and Rs 1.31 lakh of cash on hand, as presented in the cash-flow statement.

Total equity rose to Rs 487.60 crore at September 30 from Rs 459.34 crore at March 31, while total assets increased to Rs 939.13 crore from Rs 823.39 crore. The receivables increase of Rs 133.14 crore was the largest disclosed movement among current assets over that period.

Conclusion

Indogulf Cropsciences increased half-year profit before tax to Rs 38.31 crore and reduced its operating cash deficit to Rs 14.18 crore from Rs 81.69 crore a year earlier. However, the Rs 133.14 crore rise in trade receivables exceeded the Rs 51.70 crore operating profit generated before working-capital changes, preventing reported earnings from converting into positive operating cash flow.

The next financial results will show whether Indogulf Cropsciences collects the Rs 373.71 crore receivables balance and whether the Rs 66.40 crore increase in trade payables continues to offset working-capital requirements. The November 2, 2026 filing does not disclose a receivables collection target, ageing analysis or specific working-capital plan, leaving subsequent cash-flow and balance-sheet disclosures as the available measures of progress.